Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Lunning

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|October 13, 2015
Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab eraAnita Kumar, Matthew A Lunning, Zhigang Zhang, et al.
Blood|March 14, 2024
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting SystemMagdi Elsallab, Moataz Ellithi, Matthew A Lunning, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2012
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceMartin H Voss, Matthew A Lunning, Jocelyn C Maragulia, et al.
Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Journal of Oncology Practice|September 26, 2017
Bariatric Implant-Associated Anaplastic Large-Cell LymphomaJayadev Manikkam Umakanthan, Corrigan L McBride, Timothy Greiner, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Cytometry. Part B, Clinical Cytometry|December 30, 2003
Albumin enhanced morphometric image analysis in CLLMatthew A Lunning, Vincent E Zenger, Ricardo Dreyfuss, et al.
Transplantation and Cellular Therapy|December 13, 2024
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS DataMoataz Ellithi, Magdi Elsallab, Matthew A Lunning, et al.
American Journal of Hematology|August 5, 2016
Venous thromboembolism in patients with hematologic malignancy and thrombocytopeniaNabin Khanal, R Gregory Bociek, Baojiang Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|October 13, 2015
Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab eraAnita Kumar, Matthew A Lunning, Zhigang Zhang, et al.
Blood|March 14, 2024
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting SystemMagdi Elsallab, Moataz Ellithi, Matthew A Lunning, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2012
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceMartin H Voss, Matthew A Lunning, Jocelyn C Maragulia, et al.
Leukemia Research|February 7, 2018
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent dosesPatrick W Burke, Ibrahim Aldoss, Matthew A Lunning, et al.
Journal of Oncology Practice|September 26, 2017
Bariatric Implant-Associated Anaplastic Large-Cell LymphomaJayadev Manikkam Umakanthan, Corrigan L McBride, Timothy Greiner, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Cytometry. Part B, Clinical Cytometry|December 30, 2003
Albumin enhanced morphometric image analysis in CLLMatthew A Lunning, Vincent E Zenger, Ricardo Dreyfuss, et al.
Transplantation and Cellular Therapy|December 13, 2024
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS DataMoataz Ellithi, Magdi Elsallab, Matthew A Lunning, et al.
American Journal of Hematology|August 5, 2016
Venous thromboembolism in patients with hematologic malignancy and thrombocytopeniaNabin Khanal, R Gregory Bociek, Baojiang Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2013
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remissionNeha Mehta, Jocelyn C Maragulia, Allison Moskowitz, et al.
Pageof 7